MusclePharm Corporation Revenue
MusclePharm Corporation reported Revenue of $13.10 million for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2022-05-16
- MusclePharm Corporation revenues for the quarter ending 2022-03-31 was $13.10M.
- MusclePharm Corporation revenues for the quarter ending 2019-12-31 was $17.42M, a 13.62% decline year-over-year.
- MusclePharm Corporation revenues for the quarter ending 2019-09-30 was $21.18M, a 3.46% decline year-over-year.
- MusclePharm Corporation revenues for the quarter ending 2019-06-30 was $22.30M, a 2.16% increase year-over-year.
- MusclePharm Corporation revenues for fiscal 2021 was $50.04M.
- MusclePharm Corporation revenues for fiscal 2019 was $79.67M, a 9.59% decline from fiscal 2018.
- MusclePharm Corporation revenues for fiscal 2018 was $88.11M, a 5.85% decline from fiscal 2017.
- MusclePharm Corporation revenues for fiscal 2017 was $93.59M.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 6 month as first filed | Revenues 9 month | Revenues 9 month as first filed | Revenues 12 month |
|---|---|---|---|---|---|---|---|
| 2022-03-31 | $13.10M 10-Q · filed 2022-05-16 | ||||||
| 2021-12-31 | $50.04M 10-K/A · filed 2022-05-04 | ||||||
| 2019-12-31 | $17.42M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-25 | $38.59M derived: sum of 2 quarters · filed 2020-08-25 | $60.89M derived: sum of 3 quarters · filed 2020-08-25 | $79.67M 10-K · filed 2020-08-25 | |||
| 2019-09-30 | $21.18M 10-Q · filed 2020-08-25 | $43.47M derived: sum of 2 quarters · filed 2020-08-25 | $62.25M 10-Q · filed 2020-08-25 | $82.41M derived: sum of 4 quarters · filed 2020-08-25 | |||
| 2019-06-30 | $22.30M 10-Q · filed 2020-08-25 | $41.07M 10-Q · filed 2020-08-25 | $61.24M derived: sum of 3 quarters · filed 2020-08-25 | $83.17M derived: sum of 4 quarters · filed 2020-08-25 | |||
| 2019-03-31 | $18.77M 10-Q · filed 2020-08-25 | $38.94M derived: sum of 2 quarters · filed 2020-08-25 | $60.88M derived: sum of 3 quarters · filed 2020-08-25 | $82.70M derived: sum of 4 quarters · filed 2020-08-25 | |||
| 2018-12-31 | $20.16M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-25 | $42.10M derived: sum of 2 quarters · filed 2020-08-25 | $63.93M derived: sum of 3 quarters · filed 2020-08-25 | $88.11M 10-K · filed 2020-08-25 | |||
| 2018-09-30 | $21.93M 10-Q · filed 2020-08-25 | $27.39M 10-Q · filed 2018-11-14 | $43.76M derived: sum of 2 quarters · filed 2020-08-25 | $67.95M 10-Q · filed 2020-08-25 | $81.04M 10-Q · filed 2018-11-14 | $84.94M derived: sum of 4 quarters · filed 2020-08-25 | |
| 2018-06-30 | $21.83M 10-Q · filed 2020-08-25 | $27.10M 10-Q · filed 2018-08-14 | $46.01M 10-Q · filed 2020-08-25 | $53.65M 10-Q · filed 2018-08-14 | $63.00M derived: sum of 3 quarters · filed 2020-08-25 | $87.40M derived: sum of 4 quarters · filed 2020-08-25 | |
| 2018-03-31 | $24.19M 10-Q · filed 2020-08-25 | $41.18M derived: sum of 2 quarters · filed 2020-08-25 | $65.57M derived: sum of 3 quarters · filed 2020-08-25 | $91.76M derived: sum of 4 quarters · filed 2020-08-25 | |||
| 2017-12-31 | $16.99M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-25 | $41.38M derived: sum of 2 quarters · filed 2020-08-25 | $67.58M derived: sum of 3 quarters · filed 2020-08-25 | $93.59M 10-K · filed 2020-08-25 | |||
| 2017-09-30 | $24.40M 10-Q · filed 2018-11-14 | $50.59M derived: sum of 2 quarters · filed 2018-11-14 | $76.60M 10-Q · filed 2018-11-14 | ||||
| 2017-06-30 | $26.19M 10-Q · filed 2018-08-14 | $52.20M 10-Q · filed 2018-08-14 |